Posted on March 1st, 2010 by Health News
Elan Corporation, plc today announced that findings from a Phase II study which suggested bapineuzumab reduced amyloid-beta deposits in the brains of Alzheimer’s disease patients as measured using a neuroimaging technique known as [11C]PiB PET, were published in the February 28, 2010 online edition of Lancet Neurology. Bapineuzumab is a compound under development by Pfizer [...]
No Comments »
Filed under: Pharmacy News
Posted on March 1st, 2010 by Health News
The natural-occurring biopolymer known as chitosan is being put forward as an effective alternative to growth-promoting antibiotics in the diet of ruminants, according to research carried out by scientists at the Basque technological centre, Neiker-Tecnalia.
No Comments »
Filed under: Pharmacy News
Posted on March 1st, 2010 by Health News
Results released today from the Pharmacy Manpower Project’s 2009 National Pharmacist Workforce Survey indicate shifts in the pharmacy profession toward more patient care. This 2009 report also provides insight into how the nation’s current economic situation has influenced the dynamics of the U.S. pharmacy workforce as nearly a quarter of pharmacists are practicing part-time and [...]
No Comments »
Filed under: Pharmacy News
Posted on March 1st, 2010 by Health News
The Board of Directors of Ipsen, chaired by Jean-Luc Bélingard, met on 26 February 2010 to review the Group’s results for 2009, published today.
No Comments »
Filed under: Pharmacy News
Posted on March 1st, 2010 by Health News
Bone marrow transplant patients say two of the most debilitating side effects of the treatment are nausea and vomiting caused by chemotherapy and radiation.
No Comments »
Filed under: Pharmacy News
Posted on March 1st, 2010 by Health News
ADVENTRX Pharmaceuticals, Inc. announced today that it received a refuse to file letter from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for ANX-530 (vinorelbine injectable emulsion). In the letter, the FDA indicated that the data included in the initial submission from the intended commercial manufacturing site was insufficient [...]
No Comments »
Filed under: Pharmacy News
Posted on March 1st, 2010 by Health News
A recent study found that rats with advanced fibrosis that were administered a short-term dose of losartan-M6PHSA had reduced liver inflammation and fibrosis. Those animals treated with oral losartan alone did not experience a similar reduction in disease activity. Results of this study appear in the March issue of Hepatology, a journal published by Wiley-Blackwell [...]
No Comments »
Filed under: Pharmacy News
Posted on March 1st, 2010 by Health News
NPS Pharmaceuticals, a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, announced today its support for the second annual U.S. Rare Disease Day observance on February 28.
No Comments »
Filed under: Pharmacy News
Posted on March 1st, 2010 by Health News
In a study published in the March 2010 issue of The American Journal of Medicine, researchers determined that regular use of aspirin, acetaminophen and non-steroidal anti-inflammatory drugs (NSAIDs) increases the risk of hearing loss in men, particularly in younger men, below age 60.
No Comments »
Filed under: Pharmacy News
Posted on March 1st, 2010 by Health News
The following summarizes selected women’s health-related videos…
No Comments »
Filed under: Women's Health
